The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata (original) (raw)

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

Abraham Zlotogorski

EBioMedicine, 2015

View PDFchevron_right

A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata

Kerry-Ann Dillon

Clinical, Cosmetic and Investigational Dermatology, 2021

View PDFchevron_right

Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata

JCI Insight

View PDFchevron_right

Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo

Current Dermatology Reports, 2017

View PDFchevron_right

Baricitnib: from rheumatoid arthritis to alopecia areata

Omer Ahmed Shaikh

Journal of Pakistan Medical Association, 2022

View PDFchevron_right

Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature

Dermatology Online Journal, 2017

View PDFchevron_right

Acne exacerbation after tofacitinib treatment for alopecia areata

Mohammed G Turkmani

Dermatology Reports, 2021

View PDFchevron_right

The efficacy and safety of tofacitinib in patients with alopecia totalis

Journal of the American Academy of Dermatology, 2018

View PDFchevron_right

Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata

JCI insight, 2016

View PDFchevron_right

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata

Dermatology and Therapy

View PDFchevron_right

The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells

International Journal of Molecular Sciences, 2020

View PDFchevron_right

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study

Frontiers in Medicine

View PDFchevron_right

Novel therapies for alopecia areata: The era of rational drug development

Journal of Allergy and Clinical Immunology, 2018

View PDFchevron_right

A Novel Hope for Alopecia Totalis Patients: Case Report

Dubai Medical Journal, 2020

View PDFchevron_right

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients

Zekayi Kutlubay

Dermatologic Therapy, 2019

View PDFchevron_right

Ixekizumab-induced alopecia areata

Christopher Bunick

JAAD Case Reports

View PDFchevron_right

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata

Dermatology and Therapy, 2019

View PDFchevron_right

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series

Journal of the American Academy of Dermatology, 2017

View PDFchevron_right

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

mansour nassiri kashani

Journal of Dermatological Treatment, 2017

View PDFchevron_right

Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID‐19 pandemic

Dermatologic Therapy, 2021

View PDFchevron_right

Effective treatment of alopecia universalis with oral tofacitinib: A case report

Amnah N Almulhim

Our Dermatology Online, 2021

View PDFchevron_right

Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata

Tetiana V . Svyatenko

Aktualʹnì problemi sučasnoï medicini, 2023

View PDFchevron_right

Alefacept for Severe Alopecia Areata

Jonathan Lustgarten

Archives of Dermatology, 2009

View PDFchevron_right

Drug discovery for alopecia: gone today, hair tomorrow

Expert opinion on drug discovery, 2015

View PDFchevron_right

JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report

Athenaeum Scientific Publishers | Open Access Journals | Research Journals

Journal of Dermatology Research, 2024

View PDFchevron_right

Advances in the management of alopecia areata

The Journal of dermatology, 2012

View PDFchevron_right

Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report

Cathryn Sibbald

SAGE Open Medical Case Reports

View PDFchevron_right

Successful treatment of alopecia totalis with hydroxychloroquine: Report of 2 cases

Journal of The American Academy of Dermatology, 2013

View PDFchevron_right

Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata

Syed Rahman, Athenaeum Scientific Publishers | Open Access Journals | Research Journals

Journal of Dermatology Research, 2023

View PDFchevron_right

From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata

The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research, 2015

View PDFchevron_right

Subcutaneous efalizumab is not effective in the treatment of alopecia areata

Journal of the American Academy of Dermatology, 2008

View PDFchevron_right

Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study

International journal of dermatology, 2010

View PDFchevron_right

HARMACEUTICAL SCIENCES SJIF Impact Factor: 7.187 PREVALENCE AND RISK FACTORS OF ALOPECIA AREATA AMONG GENERAL POPULATION: SYSTEMATIC REVIEW QR code

View PDFchevron_right

The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata

Journal of the American Academy of Dermatology, 2020

View PDFchevron_right